Investigating how a specific protein process affects beta-thalassemia
ULK-mediated autophagy of α-globin in ß-thalassemia
This study is looking at how a special protein can help reduce harmful buildup in the blood of people with beta-thalassemia, a condition that affects hemoglobin, and it aims to find new treatment options for patients by testing this in mice.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-10888292 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of protein quality control in beta-thalassemia, a blood disorder caused by mutations that affect hemoglobin production. It explores how the Unc-51–like autophagy activating kinase 1 (ULK1) can help manage the toxic buildup of free alpha-globin, which is harmful to red blood cell development. By using a preclinical mouse model, the study examines the effects of inhibiting a specific kinase to promote the autophagy process, potentially leading to new treatment strategies for patients suffering from this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with beta-thalassemia, particularly those experiencing severe symptoms or complications.
Not a fit: Patients with other forms of anemia or blood disorders unrelated to beta-thalassemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that improve the management of beta-thalassemia and reduce complications associated with the disease.
How similar studies have performed: Previous research has shown promise in using autophagy modulation for similar blood disorders, indicating potential for success in this novel approach.
Where this research is happening
Memphis, United States
- St. Jude Children's Research Hospital — Memphis, United States (Active)
Researchers
- Principal investigator: Weiss, Mitchell J — St. Jude Children's Research Hospital
- Study coordinator: Weiss, Mitchell J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.